$GANX
Gain Therapeutics, Inc.

2024 Q4 Form 10-Q Financial Statement

#000155837024015709 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.873M
YoY Change -25.23%
% of Gross Profit
Research & Development $2.622M
YoY Change 10.74%
% of Gross Profit
Depreciation & Amortization $21.64K
YoY Change 8.25%
% of Gross Profit
Operating Expenses $4.459M
YoY Change -8.72%
Operating Profit -$4.459M
YoY Change -8.72%
Interest Expense -$15.73K
YoY Change -108.36%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.475M
YoY Change -4.73%
Income Tax $10.99K
% Of Pretax Income
Net Earnings -$4.486M
YoY Change -4.93%
Net Earnings / Revenue
Basic Earnings Per Share -$0.17
Diluted Earnings Per Share -$0.17
COMMON SHARES
Basic Shares Outstanding 26.53M 25.54M
Diluted Shares Outstanding 26.53M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.05M
YoY Change -1.5%
Cash & Equivalents $12.05M
Short-Term Investments
Other Short-Term Assets $1.318M
YoY Change 45.35%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.74M
YoY Change 3.77%
LONG-TERM ASSETS
Property, Plant & Equipment $119.6K
YoY Change -6.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $66.88K
YoY Change 37.9%
Total Long-Term Assets $624.3K
YoY Change -27.06%
TOTAL ASSETS
Total Short-Term Assets $13.74M
Total Long-Term Assets $624.3K
Total Assets $14.37M
YoY Change 1.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.100M
YoY Change -21.43%
Accrued Expenses $673.8K
YoY Change -49.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $118.3K
YoY Change 8.23%
Total Short-Term Liabilities $4.595M
YoY Change -20.28%
LONG-TERM LIABILITIES
Long-Term Debt $376.1K
YoY Change -13.52%
Other Long-Term Liabilities $485.4K
YoY Change -14.6%
Total Long-Term Liabilities $861.5K
YoY Change -14.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.595M
Total Long-Term Liabilities $861.5K
Total Liabilities $5.456M
YoY Change -19.37%
SHAREHOLDERS EQUITY
Retained Earnings -$60.78M
YoY Change
Common Stock $2.596K
YoY Change 103.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.909M
YoY Change
Total Liabilities & Shareholders Equity $14.37M
YoY Change 1.9%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$4.486M
YoY Change -4.93%
Depreciation, Depletion And Amortization $21.64K
YoY Change 8.25%
Cash From Operating Activities -$6.076M
YoY Change 53.23%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$10.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 808.7K
YoY Change 518.49%
NET CHANGE
Cash From Operating Activities -6.076M
Cash From Investing Activities -10.00
Cash From Financing Activities 808.7K
Net Change In Cash -5.268M
YoY Change 176.67%
FREE CASH FLOW
Cash From Operating Activities -$6.076M
Capital Expenditures $0.00
Free Cash Flow -$6.076M
YoY Change 53.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001819411
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
Gain Therapeutics, Inc.
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25962246
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16206680
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Interest Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet
CY2023 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Interest Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Expected Return Loss Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet
CY2023 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Expected Return Loss Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Amortization Of Gain Loss Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet
CY2023 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Amortization Of Gain Loss Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Amortization Of Prior Service Cost Credit Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet
CY2023 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Amortization Of Prior Service Cost Credit Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25962246
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16206680
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40237
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1726310
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 Montgomery Lane
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 220
dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
500-1556
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
GANX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26525068
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12049522
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11794949
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4999704
CY2024Q3 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
373726
CY2023Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
242577
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1318092
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
741638
CY2024Q3 us-gaap Assets Current
AssetsCurrent
13741340
CY2023Q4 us-gaap Assets Current
AssetsCurrent
17778868
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
119610
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
125962
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
156256
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
193375
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
281578
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
459215
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
33873
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
34021
CY2024Q3 ganx Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
33007
CY2023Q4 ganx Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
17890
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
624324
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
830463
CY2024Q3 us-gaap Assets
Assets
14365664
CY2023Q4 us-gaap Assets
Assets
18609331
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1098453
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1318965
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
178781
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
229693
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2491254
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2160366
CY2024Q3 us-gaap Deferred Income Current
DeferredIncomeCurrent
708027
CY2023Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
1122138
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
118280
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
118797
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4594795
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4949959
CY2024Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
323266
CY2023Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
307454
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
96222
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
229855
CY2024Q3 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
65869
CY2023Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
94786
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
376130
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
449053
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
861487
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1081148
CY2024Q3 us-gaap Liabilities
Liabilities
5456282
CY2023Q4 us-gaap Liabilities
Liabilities
6031107
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25962246
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16206680
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2596
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1621
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
86090657
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73113079
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
242810
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
247241
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60783717
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38516197
CY2024Q3 ganx Income Loss For Period
IncomeLossForPeriod
-16642964
CY2023Q4 ganx Income Loss For Period
IncomeLossForPeriod
-22267520
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
8909382
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12578224
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14365664
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18609331
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55180
us-gaap Revenues
Revenues
55180
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2621722
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2367482
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9566259
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9146630
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1837242
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2517523
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7453229
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8754453
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
4458964
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
4885005
us-gaap Operating Expenses
OperatingExpenses
17019488
us-gaap Operating Expenses
OperatingExpenses
17901083
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4458964
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4885005
us-gaap Operating Income Loss
OperatingIncomeLoss
-17019488
us-gaap Operating Income Loss
OperatingIncomeLoss
-17845903
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
105405
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
106000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
305239
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
387964
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-121139
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
82198
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
103362
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-20839
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4474698
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4696807
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16610887
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17478778
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10994
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21456
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32077
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64773
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4485692
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4718263
us-gaap Net Income Loss
NetIncomeLoss
-16642964
us-gaap Net Income Loss
NetIncomeLoss
-17543551
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.42
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26531747
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26531747
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12701401
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12701401
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21273422
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21273422
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12342031
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12342031
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4485692
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4718263
us-gaap Net Income Loss
NetIncomeLoss
-16642964
us-gaap Net Income Loss
NetIncomeLoss
-17543551
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
30025
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4974
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
72040
CY2024Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-1301
CY2023Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
642
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-3477
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
2012
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
229047
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-73046
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12882
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14995
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
230348
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-43663
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4431
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
55033
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4255344
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4761926
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16647395
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17488518
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12578224
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1930349
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
57711
ganx Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
113801
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-3477
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12882
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4974
us-gaap Net Income Loss
NetIncomeLoss
-16642964
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
8909382
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
11784738
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
352017
CY2024Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-1301
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
229047
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4485692
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
8909382
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18879514
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2792538
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
2012
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14995
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
72040
us-gaap Net Income Loss
NetIncomeLoss
-17543551
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
7330767
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
11092834
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
842824
CY2023Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
642
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-73046
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
30025
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4718263
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
7330767
us-gaap Profit Loss
ProfitLoss
-16642964
us-gaap Profit Loss
ProfitLoss
-17543551
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62764
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
59990
us-gaap Share Based Compensation
ShareBasedCompensation
2030830
us-gaap Share Based Compensation
ShareBasedCompensation
2703967
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
410461
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
247491
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
741103
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-25018
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
332959
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
333622
ganx Non Cash Increase Decrease In Defined Benefit Pension Plan Obligation Asset
NonCashIncreaseDecreaseInDefinedBenefitPensionPlanObligationAsset
-93069
ganx Non Cash Increase Decrease In Defined Benefit Pension Plan Obligation Asset
NonCashIncreaseDecreaseInDefinedBenefitPensionPlanObligationAsset
-762
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
41853
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
1463713
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
459360
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-1821591
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15419191
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13205494
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
21548
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
15339
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1956350
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5042502
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
9052500
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5020954
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7080811
ganx Proceeds From Issuance Of Common Stock In At Market Offerings
ProceedsFromIssuanceOfCommonStockInAtMarketOfferings
615515
ganx Proceeds From Issuance Of Common Stock In At Market Offerings
ProceedsFromIssuanceOfCommonStockInAtMarketOfferings
3147233
ganx Proceeds From Issuance Of Shares And Warrants In Public Offering
ProceedsFromIssuanceOfSharesAndWarrantsInPublicOffering
10261177
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
113801
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
57711
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
280867
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
68099
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
66488
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10699238
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3080745
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-46576
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5155
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
254425
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3038783
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11828970
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7342429
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12083395
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4303646
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12000000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
395605
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
408487
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of the Company’s consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, judgments and assumptions including those related to going concern assessment, recognition of accrued expenses, defined benefit pension liability, share-based compensation, and recognition of research grants. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable by management under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. Changes in estimates are recorded in the period in which they become </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">known. To the extent that material differences arise between the estimates and actual results, the Company’s future results of operations will be affected.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Concentrations of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has no significant off-balance sheet risk, such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. Financial instruments that may expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents which are deposited in accredited financial institutions in excess of federally insured limits. The Company deposits its cash and cash equivalents in financial institutions that it believes have high credit quality and has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</p>
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
156000
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
193000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
35000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
34000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
ganx Reduction In Research And Development Expenses Through Research Grants
ReductionInResearchAndDevelopmentExpensesThroughResearchGrants
700000
ganx Reduction In Research And Development Expenses Through Research Grants
ReductionInResearchAndDevelopmentExpensesThroughResearchGrants
200000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12049522
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11794949
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
33873
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
34021
CY2024Q3 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
373726
CY2023Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
242577
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1141261
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
608638
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
176831
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
133000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1318092
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
741638
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
241268
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
218759
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
121658
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
92797
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
119610
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
125962
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Depreciation
Depreciation
28000
us-gaap Depreciation
Depreciation
26000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
281578
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
459215
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
178781
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
229693
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
96222
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
229855
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M13D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0149
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0151
us-gaap Operating Lease Expense
OperatingLeaseExpense
185505
us-gaap Operating Lease Expense
OperatingLeaseExpense
183976
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
181587
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
92152
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
4815
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
278554
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3551
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
275003
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1100000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1300000
CY2024Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
260360
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
368345
CY2024Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1536082
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
726474
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
673811
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1016582
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
21001
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
48965
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2491254
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2160366
CY2024Q3 us-gaap Deferred Income
DeferredIncome
773896
CY2023Q4 us-gaap Deferred Income
DeferredIncome
1216924
CY2024Q3 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
3265150
CY2023Q4 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
3377290
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
494410
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
118280
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
94624
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
94624
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
94624
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
92258
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25962246
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16206680
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10100000
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1200000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
11500000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1200000
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6307193
CY2023Q4 ganx Warrants Weighted Average Exercise Price
WarrantsWeightedAverageExercisePrice
2.42
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6135380
CY2024Q3 ganx Warrants Weighted Average Exercise Price
WarrantsWeightedAverageExercisePrice
2.63
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
357505
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
816001
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2030830
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2703967
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-015709-index-headers.html Edgar Link pending
0001558370-24-015709-index.html Edgar Link pending
0001558370-24-015709.txt Edgar Link pending
0001558370-24-015709-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ganx-20240930.xsd Edgar Link pending
ganx-20240930x10q.htm Edgar Link pending
ganx-20240930xex10d2.htm Edgar Link pending
ganx-20240930xex31d1.htm Edgar Link pending
ganx-20240930xex31d2.htm Edgar Link pending
ganx-20240930xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ganx-20240930_cal.xml Edgar Link unprocessable
ganx-20240930_def.xml Edgar Link unprocessable
ganx-20240930_lab.xml Edgar Link unprocessable
ganx-20240930_pre.xml Edgar Link unprocessable
ganx-20240930x10q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable